Non-variceal upper gastrointestinal bleeding-guidelines on management

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL.2, 2008, Pages 215-229

  Celiński, Krzysztof ^a   Cichoz Lach, H ^a   Madro A ^a   Slomka M ^a   Kasztelan Szczerbinska B ^a   Dworzanski T ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Duodenal ulcer; Endoscopy; Gastric ulcer; Non variceal upper gastrointestinal bleeding; Proton pomp inhibitor

Indexed keywords

ANTIBIOTIC AGENT; ESOMEPRAZOLE; ETAMSYLATE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; THROMBIN; VASOPRESSIN; VITAMIN K GROUP;

CLINICAL TRIAL; CONFERENCE PAPER; ENDOSCOPIC THERAPY; HEALTH STATUS; HUMAN; MEDICAL SPECIALIST; PATIENT MONITORING; PATIENT REFERRAL; PRACTICE GUIDELINE; RECURRENCE RISK; RESUSCITATION; THERMOCOAGULATION; TREATMENT PLANNING; UPPER GASTROINTESTINAL BLEEDING;

COMBINED MODALITY THERAPY; ELECTROCOAGULATION; EMBOLIZATION, THERAPEUTIC; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROTON PUMP INHIBITORS; RECURRENCE;

EID: 51449092626     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (80)

1. Barkun A, Sabbah S, Enns R et al. RUGBE Investigators.The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004; 99(7): 1238-1246.
2. Barkun A, Bardou M, Marshall JK. Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. Ann Intern Med 2003; 139: 843-857.
3. Lundell L. GI haemorrhage - surgical aspects. EAGE, 2nd European Postgraduate School in Gastroenterology. Abstracts. 28-29.
4. Adler DG, Leighton JA, Davila RE et al. ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc 2004; 60: 497-504.
5. Brzozowski T, Konturek PC, Sliwowski Z et al. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. J Physiol Pharmacol 2006 Sep; 57 Suppl 3: 67-79.
6. Laine L, Petersom WL: Bleeding peptic ulcer. N Engl Med 1994; 331: 717-727.
7. British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut 2002; 51 (Suppl 4): IV1-IV6.
8. Rockall TA Logan RF, Devlin HB et. al. Risk assesment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-321.
9. Rockall TA, Logan RF, Devlin HB, Northfield TC. Selection of patients for early discharge or outpatient care after upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet 1996; 347: 1138-1140.
10. American Society for Gastrointestinal Endoscopy. An Annotated Algorithmic Approach To Upper Gastrointestinal Bleeding. Gastrointest Endosc 2001; 53: 853-858.
11. Frossard JL, Spahr L, Queneau PE et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double blind trial.Gastroenterology 2002; 123: 17-23.
12. Coffin B, Pocard M, Panis Y et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointest Endosc 2002; 56: 174-179.
13. Carbonell N, Pauwels A, Serfaty L, Boelle PY, Becquemont L, Poupon R. Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am J Gastroenterol 2006; 101: 1211-1215.
14. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394-397.
15. Sung JJ, Chan FK, Lau JY et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 2003; 139: 237-243.
16. Laine L. Systematic review of endoscopic therapy for ulcers with clots: can a meta-analysis be misleading? Gastroenterology 2005; 129: 2127.
17. Jensen DM, Machicado GA. Endoscopic hemostasis of ulcer hemorrhage with injection, thermal, and combination methods. Tech Gastrointest Endosc 2005; 7: 124-131.
18. Hui AJ, Sung JJ. Endoscopic treatment of upper gastrointestinal bleeding. Curr Treat Options Gastroenterol 2005; 8: 153-162.
19. Therapeutic endoscopy and bleeding ulcers. Natl Inst Health Consens Dev Conf Consens Statement 1989; 7: 1-7.
20. Sacks HS, Chalmers TC, Blum AL, Berrier J, Pagano D. Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers. JAMA 1990; 264: 494-499.
21. Grenvick A, Ayres SM, Holbrook PR, Shoemaker W.C. Textbook of critical care. 4th Ed. Philadelphia, WB Saunders Company, 2000, 40-45.
22. Bardou M, Youssef M, Toubouti Y et al. Newer endoscopic therapies decrease both re-bleeding and mortality in high risk patients with acute peptic ulcer bleeding: a series of meta-analyses. Gastroenterology 2003; 123 (4): A239.
23. Brullet E, Campo R, Calvet X, Coroleu D, Rivero E, Simó Deu J. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut 1996; 39: 155-158.
24. Wong SK, Yu LM, Lau JY et al. Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut 2002; 50: 322-325.
25. Thomopoulos KC, Theocharis GJ, Vagenas KA, Danikas DD, Vagianos CE, Nikolopoulou VN. Predictors of hemostatic failure after adrenaline injection in patients with peptic ulcers with non-bleeding visible vessel. Scand J Gastroenterol 2004; 39: 600-604.
26. Chung SC, Leung JW, Steele RJ Danikas DD, Vagianos CE, Nikolopoulou VN. Endoscopic injection of adrenaline for actively bleeding ulcers: a randomised trial. Br Med J 1988; 296: 1631-1633.
27. Choudari CP, Palmer KR. Endoscopic injection therapy for bleeding peptic ulcer; a comparison of adrenaline alone with adrenaline plus ethanolamine oleate. Gut 1994; 35: 608-610.
28. Chung SC, Lau JY, Sung JJ et al. Randomized comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. Br Med J 1997; 314: 1307-1311.
29. Wong RM, Ota S, Katoh A et al. Endoscopic ligation for non-esophageal variceal upper gastrointestinal hemorrhage. Endoscopy 1998; 30: 774-777.
30. Chung MG, Kim YK, Kim HM et. al. Is endoscopic band ligation more effective than electrocoagulation in the treatment of bleeding Dieulafoy's lesion? Abstract. Gastrointest Endosc 2005; 61: AB162.
31. Lau JY, Chung SC. Hemostasis: injection sclerotherapy, banding, mechanical methods, heater probe, and other methods. In: Gastroenterological Endoscopy. Classen M, Tytgat GN, Lightdale CJ (eds.). Thieme, Stuttgart 2002; 262-273.
32. Celiński K, Cichoz-Lach H. Therapeutic endoscopy in gastroenterology. J Physiol Pharmacol 2007; 58 (Suppl. 3):33-41.
33. Sung JJ, Tsoi KK, Lau JY. Hemoclips versus endoscopic injection for the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gastrointest Endosc 2007; 65: AB187.
34. Vergara M, Calvet X, Brullet E et al. Adding a second hemostatic procedure after epinephrine injection reduces rebleeding, surgery, and mortality in bleeding peptic ulcer patients: a meta-analysis. Gastrointest Endosc 2003; 57: AB 118.
35. Calvet X, Vergara M, Brullet E, Gisbert JP, Campo R. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. Gastroenterology 2004; 126: 441-450.
36. Bardou M, Martel M, Toubouti Y et al. Combination of hemoclipping and epinephrine injection decrease re-bleeding and surgery in high-risk patients with acute peptic ulcer bleeding: a meta-analysis Gastrointest Endosc 2006; 65: AB169.
37. Marmo R, Rotondano G, Falasco G et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis. Gastrointest Endosc 2005; 61: AB91.
38. Lau JY, Sung JJ, Lam YH et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999; 340: 751-756.
39. Guglielmi A, Ruzzenente A, Sandri M et al. Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy 2002; 34: 778-786.
40. Chiu PW, Joeng HK, Choi CL et al. Predictors of peptic ulcer rebleeding after scheduled second endoscopy: clinical or endoscopic factors? Endoscopy 2006; 38: 726-729
41. Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978; 74: 38-43.
42. Li Y, Sha W, Nie Y et al. Effect of intragastric pH on control of peptic ulcer bleeding. J Gastroenterol Hepatol 2000; 15: 148-154.
43. Vreeburg EM, Levi M, Rauws EA et al. Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression. Aliment Pharmacol Ther 2001; 15: 639-646.
44. Martin JE, Macaulay SS, Zarnke KB et al. Proton pump inhibitors versus H2-antagonists or placebo for upper gastrointestinal bleeding with or without endoscopic hemostasis: a meta-analysis. Gastroenterology 2003; 124 (Suppl. 1): A625.
45. Bardou M, Toubouti YM, Benhaberou-Brun D et al. High dose intravenous proton pump inhibitors decrease both re-bleeding and mortality in high-risk patients with acute peptic ulcer bleeding: a series of meta-analyses. Gastroenterology 2003; 124 (Suppl 1): A625.
46. Andriulli A, Annese V, Caruso N et al. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of metaanalyses. Am J Gastroenterol 2005; 100: 207-219.
47. Khuroo MS, Farahat KL, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a metaanalysis. J Gastroenterol Hepatol 2005; 20: 11-25.
48. Bardou M, Toubouti Y, Benhaberou-Brun D et al. Metaanalysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005; 21: 677-686.
49. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. Br Med J 2005; 330: 568.
50. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006; 1: CD002094.
51. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay - results from the Cochrane Collaboration. Aliment Pharmacol Ther 2005; 22: 169-174.
52. Wallner G, Ciechański A, Wesołowski M et al. Treatment of acute upper gastrointestinal bleeding with intravenous omeprazol or ranitidine. Eur J Clin Res 1996; 8: 235-243.
53. Röhss K, Lind T, Wilder-Smith C. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.Eur J Clin Pharmacol 2004; 60(8): 531-539.
54. Röhss K, Wilder-Smith C, Nauclér E, Jansson L. Esomeprazole 20mg provides more effective intragastric Acid control than maintenance-dose rabeprazole, lansoprazole or pantoprazole in healthy volunteers. Clin Drug Investig 2004; 24(1): 1-7.
55. Tomasz Marek, Andrzej Baniukiewicz, Grzegorz Wallner, Grażyna Rydzewska, Andrzej Da̧browski.Wytyczne postȩpowania w krwawieniu z górnego odcinka przewodu pokarmowego pochodzenia nieżylakowego. Przeglad Gastroenterol 2008; 3 (1): 1-22.
56. Lau JY, Leung WK, Wu JC et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. New Engl J Med 2007; 356: 1631-1640.
57. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000; 95: 3118-3122.
58. Mainie I, Wiggins W, Tham T. Use of intravenous pantoprazole for the treatment of acute upper gastrointestinal hemorrhage. Gastrointest. Endosc 2003; 57: AB155.
59. Enns R, Andrews C, Fishman M et al. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation. Can J Gastroenterol 2004; 18: 567-571.
60. Guda NM, Noonan M, Kreiner MJ et al. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage? Am J Gastroenterol 2004; 99: 1233-1237.
61. Mat Saad AZ, Collins N, Lobo MM, O'Connor HJ. Proton pump inhibitors: a survey of prescribing in an Irish general hospital. Int J Clin Pract 2005; 59: 31-34.
62. Zed PJ, Loewen PS, Slavik RS, Marra CA Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. Ann Pharmacother 2001; 35: 1528-1534.
63. Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology 1994; 106: 60-64.
64. Barkun AN, Cockeram AW, Plourde V, Fedorak RN. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 1999;13: 1565-1584.
65. Konturek SJ, Konturek PC, Konturek JW. et al. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation. J Physiol Pharmacol 2006; 57 (Suppl 3): 29-50.
66. Tsibouris P, Zintzaras E, Lappas C et al. High-dose pantoprazole continuous infusion is superior to somatostatin after endoscopic hemostasis in patients with peptic ulcer bleeding. Am J Gastroenterol 2007; 102: 1192-1199.
67. Saruc M, Can M, Küçükmetin N et al. Somatostatin infusion and hemodynamic changes in patients with non-variceal upper gastrointestinal bleeding: a pilot study. Med Sci Monit 2003; 9: PI84-PI87.
68. Ohmann C, Imhof M, Röher HD. Trends in peptic ulcer bleeding and surgical treatment. World J Surg 2000; 24: 284-293.
69. Schoenberg MH. Surgical therapy for peptic ulcer and nonvariceal bleeding. Langenbecks Arch Surg 2001; 386: 98-103.
70. Kazanjian KK, Hines OJ. Nonvariceal upper gastrointestinal bleeding: when endoscopic therapy fails - a surgeon's perspective. Tech Gastrointest Endosc 2005; 7: 156-159.
71. Poxon VA, Keighley MR, Dykes PW et al. Comparison of minimal and conventional surgery in patients with bleeding peptic ulcer: a multicenter trial. Br J Surg 1991; 78: 1344-1345.
72. Millat B, Hay JM, Valleur P et al. French Association for Surgical Research: emergency surgical treatment for bleeding duodenal ulcer: oversewing plus vagotomy versus gastric resection, a controlled randomized trial. World J Surg 1993; 17: 568-573.
73. Aina R, Oliva VL, Therasse E et al. Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol 2001; 12: 195-200.
74. Schenker MP, Duszak R Jr, Soulen MC et al. Upper gastrointestinal hemorrhage and transcatheter embolotherapy: clinical and technical factors impacting success and survival. J Vasc Interv Radiol 2001; 12: 1263-1271.
75. De Wispelaere JF, De Ronde T, Trigaux JP et al. Duodenal ulcer hemorrhage treated by embolization: results in 28 patients. Acta Gastroenterol Belg 2002; 65: 6-11.
76. Ripoll C, Bañares R, Beceiro I et al. Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure. J Vasc Interv Radiol 2004; 15: 447-450.
77. Wallner G, Skoczylas T, Lundell L. Management of patients with upper gastrointestinal bleeding. Pol. Prz. Chir 2007; 79(1): 89-102.
78. Konturek PC, Konturek SJ, Brzozowski T. Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol. 2006; 57 (Suppl 3): 51-65.
79. Vakil N, Fennerty MB. Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. Aliment Pharmacol Ther 2003; 18: 559-568.
80. Ramakrishnan K, Salinas RC. Peptic ulcer disease. Am Fam Physician 2007; 76: 1005-1012.